Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep;7(9):738-45.
doi: 10.1038/nrd2606.

Perspectives on NMR in drug discovery: a technique comes of age

Maurizio Pellecchia  1 , Ivano Bertini, David Cowburn, Claudio Dalvit, Ernest Giralt, Wolfgang Jahnke, Thomas L James, Steve W Homans, Horst Kessler, Claudio Luchinat, Bernd Meyer, Hartmut Oschkinat, Jeff Peng, Harald Schwalbe, Gregg Siegal
Affiliations
Review

Perspectives on NMR in drug discovery: a technique comes of age

Maurizio Pellecchia et al. Nat Rev Drug Discov. 2008 Sep.

Abstract

In the past decade, the potential of harnessing the ability of nuclear magnetic resonance (NMR) spectroscopy to monitor intermolecular interactions as a tool for drug discovery has been increasingly appreciated in academia and industry. In this Perspective, we highlight some of the major applications of NMR in drug discovery, focusing on hit and lead generation, and provide a critical analysis of its current and potential utility.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of applications of NMR in drug discovery
NMR spectroscopy can provide critical information at early stages of hit validation and identification. NMR measurements for binding studies can represent a key step to eliminate false positives from high-throughput (HTS) campaigns, to validate putative hits from in silico screens or to identify novel scaffolds in fragment-based programmes. NMR and X-ray crystallography can also provide unique information to subsequently guide hit-to-lead optimization. ADME-tox, absorption, distribution, metabolism, excretion and toxicity.
See this image and copyright information in PMC

References

    1. Pellecchia M, Sem DS, Wuthrich K. NMR in drug discovery. Nature Rev. Drug Discov. 2002;1:211–219. - PubMed
    1. Mayer M, Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angewandte Chemie International Edition. 1999;38:1784–1788. - PubMed
    1. Meyer B, et al. Saturation transfer difference NMR spectroscopy for identifying ligand epitopes and binding specificities. Ernst Schering Res. Found. Workshop. 2004:149–167. - PubMed
    1. Hajduk PJ, Olejniczak ET, Fesik SW. One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J. Am. Chem. Soc. 1997;119:12257–12261.
    1. Jahnke W, Erlanson DA, editors. Fragment-based Approaches in Drug Discovery. Wiley-VCH; 2006.

Publication types

MeSH terms